Alise Reicin Avrobio, Inc. (AVRO) insider trading activity

AVRO Quotes by TradingView

Alise Reicin is Chief Executive Officer of AVROBIO, Inc.. Currently has a direct ownership of 239,151 shares of AVRO, which is worth approximately $0. The most recent transaction as insider was on Dec 31, 2025, when has been sold 10,966 shares (Common Stock) at a price of $2.38 per share, resulting in proceeds of $26,099. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 239K
4.81% 3M change
34.13% 12M change
Total Value Held $0

ALISE REICIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2025
BUY
Exercise of conversion of derivative security
$26,099 $2.38 p/Share
10,966 Added 4.38%
239,151 Common Stock
Sep 25 2025
BUY
Grant, award, or other acquisition
-
14,700 Added 6.05%
228,185 Common Stock
Jun 20 2025
SELL
Payment of exercise price or tax liability
$17,016 $19.81 p/Share
859 Reduced 0.4%
213,485 Common Stock
Feb 04 2025
BUY
Grant, award, or other acquisition
-
36,047 Added 14.4%
214,344 Common Stock
Dec 04 2024
BUY
Grant, award, or other acquisition
-
11,717 Added 6.17%
178,297 Common Stock
Jun 20 2024
BUY
Grant, award, or other acquisition
-
166,580 Added 50.0%
166,580 Common Stock

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
FIXX
Homology Medicines, Inc. Healthcare
AR

Alise Reicin

Chief Executive Officer
Seattle, WA

Track Institutional and Insider Activities on AVRO

Follow AVROBIO, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVRO shares.

Notify only if

Insider Trading

Get notified when an Avrobio, Inc. insider buys or sells AVRO shares.

Notify only if

News

Receive news related to AVROBIO, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVRO